| [1] PubMed ID: | 33664589 |
| Disease Name: | Carcinoma, Non-Small-Cell Lung |
| Sample: | |
| Dysfunction Pattern: | Regulation(Non-Small Cell Lung Cancer) |
| Validated Method: | RNA Pull-Down//Western Blot//qRT-PCR//Luciferase Report Assay//IHC//Transwell Assay |
| Description: | The present study demonstrated that CAR10 was upregulated in patients with NSCLC, which was also associated with a poor prognosis. Functionally, CAR10 was confirmed to be oncogenic and promoted NSCLC cell migration and invasion, using overexpression and knockdown Transwell assays. Furthermore, GJB2 expression was revealed to be upregulated and was positively correlated with CAR10 expression in NSCLC. A further mechanistic study revealed that GJB2 was a downstream target of CAR10, which induced the migration and invasive potential of the A549 and H1299 cell lines. More specifically, miR-892a was found to serve as a bridge between CAR10 and GJB2, via similar miRNA response elements. The RNA pull-down and luciferase assays indicated that miR-892a directly binds both CAR10 and GJB2. |
| Causality: | Yes |
| Causal Description: | Functionally, CAR10 was confirmed to be oncogenic and promoted NSCLC cell migration and invasion, using overexpression and knockdown Transwell assays. |
| Clinical-realted Application: | The present study demonstrated that CAR10 was upregulated in patients with NSCLC, which was also associated with a poor prognosis. |